Surgical Sutures Market Report

The market is anticipated to grow as a result of a growing trend towards minimally-invasive cosmetic plastic surgery. This would create favourable prospects for the expansion of the surgical sutures market. According to the Cleveland Clinic, about 15 million cosmetic surgery treatments are performed in the United States each year. More than 13 million of these operations are minimally invasive. The rising prevalence of obesity in the population is driving up demand for bariatric surgery. This increases the need for surgical sutures used in bariatric procedures and adds to the market's quick expansion.

The innovation of surgical sutures with advanced features such knotless barbed sutures, elastic and electronic sutures, and bioactive sutures. In the near future, the accessibility of such feature-rich surgical sutures is expected to drive the global surgical sutures market. Ankle and foot fractures are among the most common types of injuries treated by orthopaedic teams globally. In orthopaedic surgery, suture materials are used to close wounds and repair fascia, ligaments, tendons, muscles, joint capsules, and tension band of specific fractures. Participation in sports and interest in different workouts and physical activities among children and adults has recently grown, leading to the majority of orthopaedic injury incidents. As a result, the orthopaedic surgery segment is expected to increase rapidly throughout the forecast period.

The availability of alternatives to wound care management solutions can slow the market's growth. Surgical sutures can be substituted by topical skin adhesives, hemostatic and sealing agents such as surgical sealants, fibrin sealants, human fibrinogen, gelatin-based sealants and thrombin fleeces, and wound closure instruments such as stapling devices, ligating clips, and wound closure strips. Some restrictions, such as cross-hatched markings, surgical site infection and the costly expense of antibacterial devices, are limiting surgeons' use of sutures. For instance, according to National Centre for Biotechnology Information statistics, about 5.0% of patients undergoing multiple surgeries each year acquire surgical site infection as a result of bacteria in the sutures. However, the surgical sutures market is projected to be hampered by a lack of skilled surgeons and high product costs.

Furthermore, the elevated cost of innovative sutures, including those with antibacterial properties or constructed from novel materials, can deter usage, especially in cost-sensitive regions. Additionally, complications such as infections or allergic reactions associated with some sutures may drive preference towards alternative wound closure methods. Furthermore, stringent cost-control measures within healthcare systems often lead to a preference for more economical, traditional suture options, limiting the market potential for advanced alternatives.

Major industry leaders utilize strategies that focus on launching new products, merging with competitors, and purchasing companies to grow their customer base and enhance their range of products. In May 2023, Johnson & Johnson's Ethicon division, led by Jesse Nawrocki, Ph.D., introduced a significant advancement in surgical sutures with their Stratafix series. Originally introduced in 2009, Stratafix sutures have revolutionized suturing by incorporating a series of anchors that enhance tissue grip and provide a watertight seal. This innovation simplifies suturing in minimally invasive procedures and reduces infection risks. The Stratafix portfolio now includes over 300 suture codes, featuring the Ethicon PLUS antibacterial technology and gaining prominence in orthopedic, general, plastic, and robotic surgeries. Nawrocki's contributions earned him the 2022 Johnson Medal.

However, Healthium Medtech, a leader in medical technology, introduced its new TRUMAS sutures in August 2023, specifically created for addressing the distinct difficulties of suturing during minimal access surgeries (MAS). In conjunction with India's 77th Independence Day, this launch showcases Healthium's commitment to improving the Indian medtech industry. The TRUMAS range features Polyglactin 910 and Polydioxanone sutures, addressing a gap in specialized solutions for MAS. This advancement aims to elevate surgical precision and outcomes, reflecting a significant leap in suturing technology for diverse medical fields.

North America is a significant contributor to the market, owing to an increase in musculoskeletal problems and increasing incidence of sports-related injuries, as well as an increase in bariatric operations and chronic diseases in the region. Another reason contributing to the growth of the surgical suture market is the increasing geriatric population, which causes an increase in chronic diseases, which leads to surgeries and hence boosts the demand for surgical sutures. As reported by the Population Reference Bureau, the number of Americans aged 65 and more will almost double from 58 million in 2022 to 82 million by 2050. This is projected to fuel the region's market expansion. There is an increase in the number of road accidents, which is leading to an increase in the number of orthopaedic injuries. For instance, the Centres for Disease Control and Prevention (CDC) forecasts that the incidence of doctor-diagnosed arthritis will rise in the next decades. An estimated 78.4 million persons aged 18 and older (25.9% of the estimated total adult population) will have doctor-diagnosed arthritis by 2040. As a result, the usage of these products in healthcare settings is increasing, and the market in this region is expanding significantly.